Atara Biotherapeutics (ATRA) Accounts Payables (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Accounts Payables of $637000.0 for Q1 2026, up 401.57% on a QoQ basis from $127000.0 in Q4 2025, and down 53.97% year-over-year from $1.4 million in Q1 2025.
Atara Biotherapeutics (ATRA) Accounts Payables (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' Accounts Payables history runs 14 years deep, the most recent figure standing at $637000.0 for Q1 2026.
- Quarterly Accounts Payables fell 53.97% year-over-year to $637000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $637000.0 (down 53.97% YoY) and the FY2025 annual result came in at $127000.0, down 97.09% from the prior year.
- Accounts Payables was $637000.0 for Q1 2026 at Atara Biotherapeutics, up from $127000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $12.8 million in Q2 2022 and bottomed at $127000.0 in Q4 2025.
- A 5-year average of $4.8 million and a median of $4.1 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables rose 26.95% — and 2025, when it tumbled 97.09%.
- Atara Biotherapeutics' Accounts Payables stood at $6.9 million in 2022, then slumped by 46.38% to $3.7 million in 2023, then rose by 18.54% to $4.4 million in 2024, then tumbled by 97.09% to $127000.0 in 2025, then jumped by 401.57% to $637000.0 in 2026.
- Business Quant data shows ATRA's Accounts Payables at $637000.0 in Q1 2026, $127000.0 in Q4 2025, and $318000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.64 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 80.54 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | 637,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 637,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 1.76 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 5.25 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Sep 30, 2023 | 6.51 Mn |
| Jun 30, 2023 | 4.14 Mn |
| Mar 31, 2023 | 5.07 Mn |
| Dec 31, 2022 | 6.87 Mn |
| Sep 30, 2022 | 11.30 Mn |
| Jun 30, 2022 | 12.80 Mn |
| Mar 31, 2022 | 11.95 Mn |
| Dec 31, 2021 | 17.37 Mn |
| Sep 30, 2021 | 16.54 Mn |
| Jun 30, 2021 | 12.30 Mn |